AAAAAA

   
Results: 1-9 |
Results: 9
A neuropsychological-neuropathological case study of variant Creutzfeldt-Jakob disease
Authors: Kapur, N Ironside, J Abbott, P Warner, G Turner, A
Citation: N. Kapur et al., A neuropsychological-neuropathological case study of variant Creutzfeldt-Jakob disease, NEUROCASE, 7(3), 2001, pp. 261-267
Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers
Authors: Barron, RM Thomson, V Jamieson, E Melton, DW Ironside, J Will, R Manson, JC
Citation: Rm. Barron et al., Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers, EMBO J, 20(18), 2001, pp. 5070-5078
Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: Implications for human health
Authors: Lasmezas, CI Fournier, JG Nouvel, V Boe, H Marce, D Lamoury, F Kopp, N Hauw, JJ Ironside, J Bruce, M Dormont, D Deslys, JP
Citation: Ci. Lasmezas et al., Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: Implications for human health, P NAS US, 98(7), 2001, pp. 4142-4147
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
Authors: Khuri, FR Nemunaitis, J Ganly, I Arseneau, J Tannock, IF Romel, L Gore, M Ironside, J MacDougall, RH Heise, C Randlev, B Gillenwater, AM Bruso, P Kaye, SB Hong, WK Kirn, DH
Citation: Fr. Khuri et al., A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer, NAT MED, 6(8), 2000, pp. 879-885
Ganciclovir implant: clinicopathological study
Authors: Al-Yousuf, NH Dhillon, B Ironside, J
Citation: Nh. Al-yousuf et al., Ganciclovir implant: clinicopathological study, EYE, 14, 2000, pp. 110-112
Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides
Authors: Soto, C Kascsak, RJ Saborio, GP Aucouturier, P Wisniewski, T Prelli, F Kascsak, R Mendez, E Harris, DA Ironside, J Tagliavini, F Carp, RI Frangione, B
Citation: C. Soto et al., Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides, LANCET, 355(9199), 2000, pp. 192-197
A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy
Authors: Manson, JC Jamieson, E Baybutt, H Tuzi, NL Barron, R McConnell, I Somerville, R Ironside, J Will, R Sy, MS Melton, DW Hope, J Bostock, C
Citation: Jc. Manson et al., A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy, EMBO J, 18(23), 1999, pp. 6855-6864
Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans
Authors: Scott, MR Will, R Ironside, J Nguyen, HOB Tremblay, P DeArmond, SJ Prusiner, SB
Citation: Mr. Scott et al., Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans, P NAS US, 96(26), 1999, pp. 15137-15142
Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas
Authors: Bennetto, L Foreman, N Harding, B Hayward, R Ironside, J Love, S Ellison, D
Citation: L. Bennetto et al., Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas, NEUROP AP N, 24(6), 1998, pp. 434-440
Risultati: 1-9 |